Smoore International Not Listed as Huabao's Main Client

Business by 2FIRSTS.ai
Dec.06.2023
Smoore International Not Listed as Huabao's Main Client
Huabao Shares denies Smoore International as its main client, clarifies on investor platform.

An investor asked on the investor interaction platform: Is Smoore International the company's main client?

Smoore International Not Listed as Huabao's Main Client

 

Huabao Group (300741.SZ) stated on December 4th on an investor interaction platform that Smoore International is currently not included among the company's main clients.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

China Tobacco Accelerates Global Cigar Expansion as CTIHK Becomes Unified Export Platform
China Tobacco Accelerates Global Cigar Expansion as CTIHK Becomes Unified Export Platform
After decades of dominance by Cuban and non-Cuban cigars, a new contender is emerging from the East. China Tobacco International (HK) has consolidated the country’s top four cigar brands under one global export platform — a move that could redefine how the world perceives “Chinese cigars.”
Nov.11
Russia’s FSB Seizes Illegal Vape Warehouse Worth USD 6 Million
Russia’s FSB Seizes Illegal Vape Warehouse Worth USD 6 Million
Russia’s Federal Security Service (FSB) in the Tula Region dismantled an underground warehouse containing counterfeit vape products worth over 500 million rubles (approximately USD 6 million). A 27-year-old suspect was detained and faces up to 12 years in prison.
Nov.06 by 2FIRSTS.ai
Denver to Hold Referendum on Flavored Tobacco Sales Ban; If Approved, Enforcement Begins in 2026
Denver to Hold Referendum on Flavored Tobacco Sales Ban; If Approved, Enforcement Begins in 2026
A referendum to be held on November 4 will determine whether Denver retains its ban on the sale of flavored tobacco/nicotine products. Campaign finance records show that, as of the end of August, the side seeking to repeal the ban had raised $410,000, significantly more than the pro-ban side (about $245,000). The ban took effect in March 2025, but the city had planned to begin enforcement on January 2026; if the referendum overturns the ban, enforcement will not proceed.
Sep.25 by 2FIRSTS.ai
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai
South Korea's National Assembly Planning and Finance Committee passed a revised bill for the Tobacco Act, which includes synthetic nicotine in the tobacco category
South Korea's National Assembly Planning and Finance Committee passed a revised bill for the Tobacco Act, which includes synthetic nicotine in the tobacco category
The Planning and Finance Committee of the National Assembly of South Korea passed an amendment to the Tobacco Business Act, which includes "tobacco" or "nicotine" in the definition of tobacco, and officially defines synthetic nicotine as tobacco.
Sep.23 by 2FIRSTS.ai
Feature | Vape Politics in Russia: Local Governments Push Forward Despite Legislative Deadlock
Feature | Vape Politics in Russia: Local Governments Push Forward Despite Legislative Deadlock
As Russia’s federal vape policy stalls, regional governors are racing to implement local bans—now with the backing of President Vladimir Putin. The divide between swift local action and delayed national legislation is fueling debate over health, regulation, and the country’s broader approach to nicotine control.
Oct.28